Want to see IL:NRGN full AI Analyst Report?
NRGN Stock Chart & Stats
204.80
0.03(0.96%)
At close: 4:00 PM EST
204.80
0.03(0.96%)
Day’s Range― - ―
52-Week Range140.70 - 305.90
Previous CloseN/A
Volume1.26K
Average Volume (3M)27.56K
Market Cap
₪21.87M
Enterprise Value5.76M
Total Cash (Recent Filing)₪5.30M
Total Debt (Recent Filing)₪181.00K
Price to Earnings (P/E)―
Beta0.60
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding13,327,785
10 Day Avg. Volume57,803
30 Day Avg. Volume27,561
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)1.94
Price to Sales (P/S)2.64
P/FCF Ratio116.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Rebound And Margin ExpansionThe sharp revenue recovery and materially higher gross margin indicate improved commercial traction and unit economics. If sustained, these gains could provide a stronger foundation for scaling the software and genomics services business.
Improved Operating Cash GenerationThe move from several years of operating cash burn to positive operating cash flow is an important operational improvement. It suggests better cash conversion and lowers near-term reliance on external funding, even though durability remains unproven.
Conservative LeverageVery low leverage gives the company financial flexibility and limits interest-related pressure while it works toward profitability. A relatively unencumbered balance sheet may also support continued investment in its genomics software and services.
Bears Say
Persistent Operating LossesDespite revenue and gross-margin improvement, the company still generates substantial net and operating losses. This shows that the current scale and cost structure have not yet produced sustainable earnings power, leaving execution risk over the next several quarters.
Unproven Free Cash Flow DurabilityPositive free cash flow was modest and volatile after several years of deeply negative cash flow. Limited conversion of improved operations into durable cash generation could constrain reinvestment capacity and increase future financing dependence.
Weak Returns And Equity-Base RiskNegative returns show that shareholder capital is not yet generating value through profits. The history of equity-base fluctuation, including negative equity in 2020, highlights the potential for ongoing losses to weaken financial resilience if profitability does not improve.
NRGN FAQ
What was NRGENE TECHNOLOGIES LTD’s price range in the past 12 months?
NRGENE TECHNOLOGIES LTD lowest stock price was 140.70 and its highest was 305.90 in the past 12 months.
What is NRGENE TECHNOLOGIES LTD’s market cap?
NRGENE TECHNOLOGIES LTD’s market cap is ₪21.87M.
When is NRGENE TECHNOLOGIES LTD’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were NRGENE TECHNOLOGIES LTD’s earnings last quarter?
Currently, no data Available
Is NRGENE TECHNOLOGIES LTD overvalued?
According to Wall Street analysts NRGENE TECHNOLOGIES LTD’s price is currently Overvalued.
Does NRGENE TECHNOLOGIES LTD pay dividends?
NRGENE TECHNOLOGIES LTD does not currently pay dividends.
What is NRGENE TECHNOLOGIES LTD’s EPS estimate?
NRGENE TECHNOLOGIES LTD’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NRGENE TECHNOLOGIES LTD have?
NRGENE TECHNOLOGIES LTD has 13,327,785 shares outstanding.
What happened to NRGENE TECHNOLOGIES LTD’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NRGENE TECHNOLOGIES LTD?
Currently, no hedge funds are holding shares in IL:NRGN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NRGENE TECHNOLOGIES LTD
NRGene Technologies Ltd is an AI-powered genomics firm that designs sophisticated computational tools and advanced algorithms, serving clients globally across North America, Europe, the Middle East, Africa, and Asia Pacific. The company provides specialized software applications and complete, ready-to-use solutions for various sectors, including agricultural breeding, food technology, academia, research institutions, and agribiotech enterprises. Additionally, NRGene develops custom genetic panels tailored for a broad range of plants, from staple crops like wheat, canola, corn, soybeans, and maize to cannabis. Established in 2009, its headquarters are located in Ness Ziona, Israel.